Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Sorafenib

Nexavar®, Sorafenib is anti cancer drug multikinase inhibitor,  film coated tablets, indicated for the treatment of:

  • Renal cell carcinoma
    Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma.
  • Hepatocellular Carcinoma
    Nexavar is indicated for the treatment of patients with hepatocellular carcinoma see section
  • Differentiated thyroid carcinoma
    Nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.

To Read More>>

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Close Menu